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The abnormal erythrocytes of patients with paroxysmal nocturnal hemoglo-
binuria (PNH) are deficient in decay-accelerating factor (DAF) (1, 2) . DAF is a
membrane-associated complement regulatory protein that accelerates the spon-
taneous decay of the classical (3) and the alternative C3 convertase (1) and
inhibits assembly of these enzymes (4). The protein is a membrane constituent
of normal human E (3), platelets, polymorphonuclear leukocytes, monocytes,
lymphocytes (5, 6), and endothelial cells (7). DAF deficiency explains the mark-
edlyextended half-life ofC3 convertase on the surface ofPNH-E (1, 8) compared
with normal cells and therefore, at least in part, the susceptibility of PNH-E to
lysis in serum acidified to pH 6 .4 (9) . However, DAF deficiency does not account
for the enhanced sensitivity of PNH-E to reactive lysis by C5b-9 (10, 11) . Both
C9 binding and C9 polymerization have been reported to be abnormally high
on PNH-E (12) .
Recently, we isolated (13) from human E a membrane protein called the
homologous restriction factor (HRF) that can inhibit complement-mediated
transmembrane channel expression, including the C5b-8, C5b-9, and tubular
poly C9 channels (13) . Antibody produced to isolated HRF caused a marked
enhancement of reactive lysis of normal human E by C5b-9 and an increase in
C9 uptake . Because anti-HRF treated normal human E resembled PNH-E in
susceptibility to reactive lysis, the question arose as to whether PNH-E are
deficient in HRF. Therefore, the E of two patients with PNH were examined
and in both cases the affected E lacked the HRF protein.
Materials and Methods
BriefDefinitive Report
Isolation ofHRF .
￿
Hemoglobin-free E membranes (^-200 mg protein) were dissolved
in 2% deoxycholate (DOC), 50 mM NaCl, 2 mM PMSF, 1 mM benzamidine, 2 mM
EDTA, 2 mM EGTA, 20 mM Tris-HCI, pH 8 .4, at 4°C overnight in a total volume of
100 ml . The mixture wascentrifuged at 12,000gfor 30 min to remove particulate matter
and the supernatant was dialyzed against 0.02% DOC, 50 mM NaCl, 20 mM Tris-HCl,
pH 8 .4 (starting buffer) . The material was applied to a Sepharose column containing 300
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FIGURE 1 .
￿
Anti-HRF immunoblot of PNH and normal E membranes . Samples of 50 ug of
protein of dissolved E membranes of PNH patient TF, PNH patient KM, and of two normal
individuals were subjected to SDS-PAGE (1 .7-17% acrylamide) .The material was transferred
onto nitrocellulose paper and probed with rabbit anti-HRF . Thepattern wasdeveloped with
goat anti-rabbit horseradish peroxidase conjugate . Molecular mass standards are shown at
left .
mg ofbound anti-HRF Ig . The column was washed with five column volumes of starting
buffer and HRF was eluted with 2M NaCl in starting buffer and then with 2 M KBr.
The final yield was ^-850 ug of protein. To maintain the protein in solution it was
necessary to have 0.02% ofDOC in the buffer .
Separation ofPNH-Efrom Normal E.
￿
The PNH-E population of patients TF and KM
was enriched by treating the E with anti-DAF and guinea pig serum. 2 x 109 E were
incubated with 500 tl of rabbit anti-DAF for 30 min at 37°C, washed twice, and further
incubated with 1 ml of fresh guinea pig serum for 10 min at 37 °C . ^-60% of the E ofTF
and 42% ofKM were lysed under these conditions and the remaining cells were washed
and used as PNH-E .
Functional Assayfor Cell-Bound HRF .
￿
10 7 normal or 107 abnormal PNH-E in 10 Al
were incubated with various amounts of anti-HRF for 30 min at 4°C . The cells were
washed twice with 0.01 M EDTA containing veronal buffer, pH 7 .4, and were subjected
to reactive lysis by isolated C5b6, C7, C8, and C9 as described (13) .
Insertion of "5I-HRF into PNH-E.
￿
Purified HRF was radiolabeled with ` 25 1 to 2.8 X
106 cpm/,ug using the iodogen method (Pierce Chemical Co ., Rockford, IL). 5 x 107
PNH-E were incubated with varying amounts of HRF in 20 I,1 of0.02% DOC or 20 Al of
0.02% DOC alone (control) in a total volume of 1 .04 ml for 2 h at 37°C . The cells were
washed twice and the amount ofHRF incorporated was determined .
Results
Lack ofHRF in Membranes of the Abnormal PNH-E .
￿
The blood of patient KM
contained 58% and that of TF 40% abnormal E as determined by the acidified
(pH 6 .4) serum lysis test . The unlysed cells were considered normal . To enrich
the abnormal cells, E of both individuals were treated with anti-DAF and guinea
pig serum. This treatment lysed the DAF containing normal cells (42 and 60%
for KM and TF, respectively) and left the DAF-deficient abnormal cells intact .
The membranes of the enriched abnormal cells were dissolved and subjected to
SDS-PAGE and immunoblotting (Fig . 1) . Compared with normal human E, the
abnormal cells clearly lacked the 65-kD protein detected by the anti-HRF.
Lack ofEnhancement by Anti-HRF ofReactive Lysis ofPNH-E.
￿
Anti-HRF inhib-574
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FIGURE 2 .
￿
Effect of anti-HRF on reactive lysis of PNH (0) and normal human E (Q) . 107 E
(normal or PNH) were treated with 0, 2.5, 5, or 10 pl of anti-HRF for 30 min at 4 °C. The
cells were washed and subjected to reactive lysis with isolated human C5b6, C7, C8, and C9
for 30 min at 37°C .
ited HRFactivity on normal human E, allowing reactive lysis by C5b-9 to increase
from 1 .0 to 20% . No such effect was observed with the abnormal PNH-E (Fig .
2) . Lysis in absence of anti-HRF was 14% and did not increase with antibody
addition . It was not explored why the antiserum caused a reduction in lysis of
PNH-E . The normal E population ofKM obtained after lysis of the PNH cells
in acidified serum was also tested and behaved like the normal E control shown
in Fig. 2 .
Effect of Insertion of Exogenous HRF into the Membrane ofPNH-E.
￿
121I-HRF
isolated from normal E membranes in buffer containing 0.02% DOC was
incubated with the enriched abnormal PNH-E ofTF for 1 h at 37°C and I h at
30°C in the presence ofDOC (final concentration, 0.0004%) . The concentration
ofHRF ranged from 150 to 1,540 ng/ml and the cell concentration was 4.8 X
10'/ml . The cells were washed and the cell-associated radioactivity determined .
Uptake of t25I-HRF was 2-3% of input and the number of HRF molecules
bound per cell ranged from 144 to 2,700 . With increasing HRF incorporation,
reactive lysis by C5b-9 decreased from 230% of the normal control to 110%
(Fig . 3) . Increasing the number ofHRF molecules per cell from 1,080 to 2,700
did not further decrease the cell sensitivity to reactive lysis .
Effect of Anti-HRF on the Lysis of Normal Human E by Acidified Human
Serum . Anti-HRF by itself did not render normal E susceptible to lysis by
acidified serum. However, it did enhance the induction of lysis by anti-DAF in
10mM EGTA containing acidified serum (not shown) .
Discussion
DAF deficiency of the affected E in PNH explains in part their abnormal
sensitivity to complement . Incorporation of exogenous DAF into the membranes
of the affected PNH cells decreased their susceptibility to lysis in acidified serum
(14) . Treatment of normal human E with anti-DAF rendered these cells suscep-
tible to lysis in acidified serum (14, 15) . DAF was found normally expressed onZALMAN ET AL .
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FIGURE 3 .
￿
Inhibition of reactive lysis by isolated HRF inserted into abnormal PNH-E .
erythroid progenitors of PNH bone marrow and this expression was lost during
differentiation in vitro (16) . DAF was shown to be anchored in the cell membrane
by a glycolipid involving phosphatidylinositol (17) and it is possible that DAF
deficiency is due to an acquired defect in the attachment mechanism .
It has been established that PNH-E are also abnormally sensitive to reactive
lysis by C5b-9 (10) and that this sensitivity is seen only when the C9 used is of
human origin, but not when the C9 is from another species (18) . This work
suggested the existence of a regulatory mechanism on normal human E designed
to inhibit the function of the membrane attack complex and related the postu-
lated regulation to the phenomenon of homologous species restriction (19) . The
latter term refers to the observation that lysis by complement is inefficient when
C8 and C9 are of the same species as the target cells . Since DAF lacks the ability
to interfere with C8 or C9 action (11), human E membranes were explored for
the presence of a protein that could interact withC8 or C9 .A C8 bindingprotein
(C8bp) was described (20) that functioned as an inhibitor in the lysis of chicken
E bearing C5b-7 by human C8 and C9 .
The HRF isolated previously (13) exhibits affinity for human C8 and C9 and
is probably closely related to C8bp . Anti-HRF rendered normal human E PNH-
like with respect to susceptibility to reactive lysis . The enhancing effect of anti-
HRF in this system was seen only when C8 and C9 were of human origin . HRF
has also been detected on the surface of polymorphonuclear leukocytes, Raji
lymphoblastoid cells (13), as well as monocytes and lymphocytes .
The data presented above indicate that in the two cases studied, the abnormal
PNH-E membranes lack the HRF protein and activity . This findingsuggests that
HRF deficiency constitutes an additional molecular defect in PNH. Since both
of the other missing proteins, DAF (17) and acetylcholinesterase (21) are linked
to the membrane of normal E by phosphatidylinositol, it has been suggested (17)
that it is the biosynthetic pathway generating the anchoring mechanism that is
defective in this disease . It is conceivable that HRF is also anchored through
phosphatidylinositol .57 6
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Whereas up to 2,700 molecules of isolated 121I-HRF were inserted into the
abnormal PNH cells, ^1,000 molecules were sufficient to reduce the sensitivity
of the cells to reactive lysis close to the normal level. Anti-HRF did not render
normal human E susceptible to lysis by acidified serum. However, , anti-HRF
enhanced lysis induced by anti-DAF, further demonstrating the two distinct
regulatory mechanisms of normal E, DAF functioning at the C3/C5 convertase
stage and HRF at the stage of C8/C9 action .
Summary
The affected E of two patients with - paroxysmal nocturnal hemoglobinuria
(PNH) were enriched by lysing the unaffected, normal E with anti-human decay-
accelerating factor (DAF) and guinea pig serum . The membranes of the unlysed,
DAF-deficient cells (PNH-E) were dissolved and examined by SDS-PAGE and
immunoblotting using an antiserum to homologous restriction factor (HRF).
Whereas the 65 kD complement regulatory protein was readily detectable in the
normal controls, it was completely lackingin both samples ofPNH-E membranes .
Functional studies likewise indicated the absence ofHRF activity from PNH-E.
When radiolabeled, isolated HRF protein was offered to PNH-E, it became
firmly attached to the cells . ^-1,000 molecules of HRF per cell reduced the
characteristic susceptibility of these cells to reactive lysis by C5b-9 to nearly
normal levels . The results suggest that HRF, which is known to control the
action of C8 and C9 on normal human E membranes, is deficient in PNH, as
well as acetylcholinesterase and DAF.
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